Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary

Clearpoint Neuro

09/08/2023 06:27

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly
adjusted
loss of 29 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 19 cents per share.
    * Revenue rose 14.4% to $5.95 million from a year ago;
analysts
expected $5.90 million. 
    * Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 29 cents​.
    * The mean earnings estimate of analysts had fallen by
about 15.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearpoint Neuro Inc shares had fallen by 11.6% this
quarter and
lost 24.4% so far this year.
    * The company reported a quarterly loss of $7.05 million.
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 05:27 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.19          -0.29          Missed
 Mar. 31 2023      -0.18          -0.23          Missed
 Dec. 31 2022      -0.20          -0.18          Beat
 Sep. 30 2022      -0.19          -0.15          Beat